Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology-Reference-Cited by-同舟云学术

Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology

Published:2022-09-20 Issue:10 Volume:24 Page:1767-1777
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European J of Heart Fail

Author:

Bayes‐Genis Antoni¹²³^ORCID,Aimo Alberto⁴⁵,Jhund Pardeep⁶,Richards Mark⁷,de Boer Rudolf A.⁸,Arfsten Henrike⁹,Fabiani Iacopo⁵,Lupón Josep¹,Anker Stefan D.¹⁰,González Arantxa³¹¹,Castiglione Vincenzo⁴,Metra Marco¹²,Mueller Christian¹³,Núñez Julio³¹⁴,Rossignol Patrick¹⁵,Barison Andrea⁵,Butler Javed¹⁶,Teerlink John¹⁷,Filippatos Gerasimos¹⁸,Ponikowski Piotr¹⁹,Vergaro Giuseppe⁴⁵,Zannad Faiez²⁰,Seferovic Petar²¹²²,Rosano Giuseppe²³,Coats Andrew J.S.²⁴,Emdin Michele⁴⁵,Januzzi James L.²⁵

Affiliation:

1. Institut del Cor Hospital Universitari Germans Trias i Pujol Barcelona Spain

2. Department of Medicine Universitat Autònoma de Barcelona Barcelona Spain

3. CIBERCV, Carlos III Institute of Health Madrid Spain

4. Scuola Superiore Sant'Anna Pisa Italy

5. Cardiology Division Fondazione Toscana Gabriele Monasterio Pisa Italy

6. Institute of Cardiovascular & Medical Sciences University of Glasgow Glasgow UK

7. University of Otago Dunedin New Zealand

8. Department of Cardiology University Medical Centre Groningen Groningen The Netherlands

9. Clinical Division of Cardiology, Department of Internal Medicine II Medical University of Vienna Vienna Austria

10. Department of Cardiology (CVK), and Berlin Institute of Health Center for Regenerative Therapy (BCRT), German Center for Cardiovascular Research (DZHK) partner site Berlin Charité Universitätsmedizin Berlin Germany

11. Program of Cardiovascular Diseases CIMA Universidad de Navarra and IdiSNA, Navarra Institute for Health Research Pamplona Spain

12. Cardiology Department, ASST Spedali Civili; Department of Medical and Surgical Specialties, Radiological Sciences and Public Health University of Brescia Brescia Italy

13. Department of Cardiology University Hospital Basel Switzerland

14. Hospital Clínico Universitario de Valencia, INCLIVA Universidad de Valencia Valencia Spain

15. Academic Hospital (CHU) Nancy France

16. Department of Medicine University of Mississippi Medical Center Jackson MS USA

17. Heart Failure and of the Echocardiography Laboratory San Francisco Veterans Affairs Medical Center San Francisco CA USA

18. HF Unit Attikon University Hospital Athens Greece

19. Centre for Heart Diseases University Hospital Wroclaw Poland

20. Université de Lorraine, Centre d'Investigations Cliniques‐Plurithématique 1433, and Inserm U1116 CHRU Nancy, F‐CRIN INI‐CRCT Nancy France

21. Department of Cardiology University Clinical Center of Serbia Belgrade Serbia

22. Serbian Academy of Sciences and Arts Belgrade Serbia

23. IRCCS San Raffaele Rome Italy

24. University of Warwick Coventry UK

25. Massachusetts General Hospital and Baim Institute for Clinical Research Boston MA USA

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.2675

Reference78 articles.

1. Gaining Efficiency in Clinical Trials With Cardiac Biomarkers

2. Statista. Success rate of novel cardiovascular disease drugs by development phase in the United States in 2008‐2019.https://www.statista.com/statistics/1186648/us‐clinical‐development‐success‐rate‐novel‐cardiovascular‐drugs(accessed 13 September 2022).

3. Biotechnology Innovation Organization.Clinical Development Success Rates 2006–2015. June 2016.https://www.bio.org/sites/default/files/legacy/bioorg/docs/Clinical%20Development%20Success%20Rates%202006‐2015%20‐%20BIO %20Biomedtracker %20Amplion%202016.pdf(accessed 13 September 2022).

4. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework

5. Biomarkers for the diagnosis and management of heart failure

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reverse cardiac remodelling: VICTORIA for inflammation and cardiac metabolism;European Journal of Heart Failure;2024-08-15

2. Comprehensive Quality Analysis of Conventional and Novel Biomarkers in Diagnosing and Predicting Prognosis of Coronary Artery Disease, Acute Coronary Syndrome, and Heart Failure, a Comprehensive Literature Review;Journal of Cardiovascular Translational Research;2024-07-12

3. Heart Failure Drug Development Over the Eras;JACC: Heart Failure;2024-07

4. 2024 update in heart failure;ESC Heart Failure;2024-05-28

5. Insulin‐like growth factor binding protein‐7 in heart failure: The challenge of moving from risk prediction to a biomarker‐guided management;European Journal of Heart Failure;2024-05-13